FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets

Journal of Bone and Mineral Metabolism

Volumn 30, Issue 1, 2012, Pages 78-84

  Sun, Yue ^a,b   Wang, Ou ^a   Xia, Weibo ^a   Jiang, Yan ^a   Li, Mei ^a   Xing, Xiaoping ^a   Hu, Yingying ^a   Liu, Huaicheng ^a   Meng, Xunwu ^a   Zhou, Xueying ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Autosomal dominant hypophosphatemic rickets; Chinese; FGF23; Mutation; Phosphatonins

Indexed keywords

ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR 23; GENOMIC DNA; PHOSPHORUS;

ADULT; ANKLE EDEMA; ANKLE PAIN; ARTICLE; AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS; BACKACHE; BLUNT TRAUMA; CASE REPORT; CHINESE; CONTROLLED STUDY; FATIGUE; FEMALE; FIBROBLAST GROWTH FACTOR 23 GENE; GENE; HETEROZYGOSITY; HUMAN; HYPOPHOSPHATEMIA; MALE; MISSENSE MUTATION; PEDIGREE ANALYSIS; PENETRANCE; PHOSPHORUS TUBULE MAXIMUM TO GLOMERULAR FILTRATION RATE RATIO; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; RICKETS; SEQUENCE ANALYSIS; TOOTH ABSCESS; WALKING DIFFICULTY; WEAKNESS;

ADMINISTRATION, ORAL; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; FAMILY; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEDIGREE; PHOSPHATES; PHOSPHORUS;

EID: 84863369043     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-011-0285-5     Document Type: Article

References (26)

1. Econs MJ, McEnery PT (1997) Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocr Metab 82:674-681 (Pubitemid 27068650)
2. Bianchine JW, Stambler AA, Harrison HE (1971) Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig Artic Ser VII:287-294
3. Imel EAHS, Econs MJ (2007) FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 22:520-526
4. Negri AL, Negrotti T, Alonso G, Pasqualini T (2004) Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family. Medicina (B Aires) 64:103-106 (Pubitemid 39199686)
5. Consortium ADHR (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345-348
6. White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079-2086 (Pubitemid 33070451)
7. Bai XY, Miao D, Goltzman D, Karaplis AC (2003) The autosomal dominant hypophosphatemic rickets r176q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 278:9843-9849 (Pubitemid 36800487)
8. Kiela PR, Ghishan FK (2009) Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis. Lab Invest 89:7-14
9. Tiosano D, Hochberg Z (2009) Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab 27:392-401
10. Weber TJ, Liu S, Indridason OS, Quarles LD (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18:1227-1234 (Pubitemid 37294915)
11. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656-1663 (Pubitemid 36459471)
12. Bijvoet OL, Morgan DB, Fourman P (1969) The assessment of phosphate reabsorption. Clin Chim Acta 26:15-24
13. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length Fgf-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87:4957-4960 (Pubitemid 35316332)
14. Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91:2055-2061 (Pubitemid 43854981)
15. Xia W, Meng X, Jiang Y, Li M, Xing X, Pang L, Wang O, Pei Y, Yu LY, Sun Y, Hu Y, Zhou X (2007) Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets. Calcif Tissue Int 81:415-420
16. Gribaa M, Younes M, Bouyacoub Y, Korbaa W, Ben Charfeddine I, Touzi M, Adala L, Mamay O, Bergaoui N, Saad A (2009) An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J Bone Miner Metab 28:111-115. doi:10.1007/s00774-009-0111-5
17. Wilson DR, York SE, Jaworski ZF, Yendt ER (1965) Studies in hypophosphatemic vitamin D-refractory osteomalacia in adults: oral phosphate supplements as an adjunct to therapy. Medicine (Baltim) 44:99-134
18. Harrison HE, Harrison HC, Lifshitz F, Johnson AD (1966) Growth disturbance in hereditary hypophosphatemia. Am J Dis Child 112:290-297
19. Pettifor JM (2008) What's new in hypophosphataemic rickets. Eur J Pediatr 167:493-499
20. Kruse K, Woelfel D, Storm TM (2001) Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation. Horm Res 55:305-308 (Pubitemid 34114179)
21. Yamashita T (2005) Structural and biochemical properties of fibroblast growth factor 23. Ther Apher Dial 9:313-318
22. Mirams M, Robinson BG, Mason RS, Nelson AE (2004) Bone as a source of FGF23: regulation by phosphate? Bone (NY) 35:1192-1199 (Pubitemid 39487366)
23. Liu S, Gupta A, Quarles LD (2007) Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 16:329-335 (Pubitemid 46944331)
24. Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients. Proposal of diagnostic criteria using FGF23 measurement. Bone (NY) 42:1235-1239
25. Laroche M, Boyer JF, Jahafar H, Allard J, Tack I (2009) Normal FGF23 levels in adult idiopathic phosphate diabetes. Calcif Tissue Int 84:112-117
26. Ito N, Fukumoto S, Takeuchi Y, Takeda S, Suzuki H, Yamashita T, Fujita T (2007) Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 25:419-422 (Pubitemid 350043699)